
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Oncology Today with Dr Neil Love
00:00
CRS Management and Tosyllizumab
I'm not sure that the jury is out on by T-cell engagers and the immediate necessity of tosyllizumab. 10 milligrams of dexamethasone is a heck of a lot cheaper and a heck of an lot more accessible than tosylzumab. We have to come as come together as a community to analyze the situation because you know if you're going to use this in I'll just pick a pick a town in Nebraska if you can use this in Grand Island Nebraska.
Transcript
Play full episode